Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas.

Andreasson A, Kiss NB, Caramuta S, Sulaiman L, Svahn F, Bäckdahl M, Höög A, Juhlin CC, Larsson C.

Epigenetics. 2013 Dec;8(12):1347-54. doi: 10.4161/epi.26686.

2.

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.

López-Jiménez E, Gómez-López G, Leandro-García LJ, Muñoz I, Schiavi F, Montero-Conde C, de Cubas AA, Ramires R, Landa I, Leskelä S, Maliszewska A, Inglada-Pérez L, de la Vega L, Rodríguez-Antona C, Letón R, Bernal C, de Campos JM, Diez-Tascón C, Fraga MF, Boullosa C, Pisano DG, Opocher G, Robledo M, Cascón A.

Mol Endocrinol. 2010 Dec;24(12):2382-91. doi: 10.1210/me.2010-0256.

PMID:
20980436
3.

Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.

de Cubas AA, Leandro-García LJ, Schiavi F, Mancikova V, Comino-Méndez I, Inglada-Pérez L, Perez-Martinez M, Ibarz N, Ximénez-Embún P, López-Jiménez E, Maliszewska A, Letón R, Gómez Graña A, Bernal C, Alvarez-Escolá C, Rodríguez-Antona C, Opocher G, Muñoz J, Megias D, Cascón A, Robledo M.

Endocr Relat Cancer. 2013 Jun 24;20(4):477-93. doi: 10.1530/ERC-12-0183.

4.

Role of SDHAF2 and SDHD in von Hippel-Lindau associated pheochromocytomas.

Kugelberg J, Welander J, Schiavi F, Fassina A, Bäckdahl M, Larsson C, Opocher G, Söderkvist P, Dahia PL, Neumann HP, Gimm O.

World J Surg. 2014 Mar;38(3):724-32. doi: 10.1007/s00268-013-2373-2.

PMID:
24322175
5.

Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.

Korpershoek E, Petri BJ, van Nederveen FH, Dinjens WN, Verhofstad AA, de Herder WW, Schmid S, Perren A, Komminoth P, de Krijger RR.

Endocr Relat Cancer. 2007 Jun;14(2):453-62.

6.

Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma.

Galan SR, Kann PH.

Clin Endocrinol (Oxf). 2013 Feb;78(2):165-75. doi: 10.1111/cen.12071. Review.

PMID:
23061808
7.

Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.

Tsang VH, Dwight T, Benn DE, Meyer-Rochow GY, Gill AJ, Sywak M, Sidhu S, Veivers D, Sue CM, Robinson BG, Clifton-Bligh RJ, Parker NR.

Endocr Relat Cancer. 2014 May 6;21(3):415-26. doi: 10.1530/ERC-13-0519.

8.

Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.

Pandit R, Khadilkar K, Sarathi V, Kasaliwal R, Goroshi M, Khare S, Nair S, Raghavan V, Dalvi A, Hira P, Fernandes G, Sathe P, Rojekar A, Malhotra G, Bakshi G, Prakash G, Bhansali A, Walia R, Kamalanathan S, Sahoo J, Desai A, Bhagwat N, Mappa P, Rajput R, Chandrashekhar SR, Shivane V, Menon P, Lila A, Bandgar T, Shah N.

Eur J Endocrinol. 2016 Oct;175(4):311-23. doi: 10.1530/EJE-16-0126.

PMID:
27539324
9.

Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma.

Burnichon N, Buffet A, Parfait B, Letouzé E, Laurendeau I, Loriot C, Pasmant E, Abermil N, Valeyrie-Allanore L, Bertherat J, Amar L, Vidaud D, Favier J, Gimenez-Roqueplo AP.

Hum Mol Genet. 2012 Dec 15;21(26):5397-405. doi: 10.1093/hmg/dds374.

PMID:
22962301
10.

Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.

Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, Hunt T, Jeffery R, Seedhar P, Barwell J, Latif F, Gleeson MJ, Hodgson SV, Stamp GW, Tomlinson IP, Maher ER.

J Clin Endocrinol Metab. 2006 Nov;91(11):4593-8.

PMID:
16954163
11.

Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.

Shankavaram U, Fliedner SM, Elkahloun AG, Barb JJ, Munson PJ, Huynh TT, Matro JC, Turkova H, Linehan WM, Timmers HJ, Tischler AS, Powers JF, de Krijger R, Baysal BE, Takacova M, Pastorekova S, Gius D, Lehnert H, Camphausen K, Pacak K.

Neoplasia. 2013 Apr;15(4):435-47.

12.

Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Fishbein L, Nathanson KL.

Cancer Genet. 2012 Jan-Feb;205(1-2):1-11. doi: 10.1016/j.cancergen.2012.01.009. Review.

13.

Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior.

Geli J, Kiss N, Karimi M, Lee JJ, Bäckdahl M, Ekström TJ, Larsson C.

Clin Cancer Res. 2008 May 1;14(9):2551-9. doi: 10.1158/1078-0432.CCR-07-1867.

14.

An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.

Gimenez-Roqueplo AP, Dahia PL, Robledo M.

Horm Metab Res. 2012 May;44(5):328-33. doi: 10.1055/s-0031-1301302. Review.

PMID:
22328163
15.

Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.

Welander J, Andreasson A, Juhlin CC, Wiseman RW, Bäckdahl M, Höög A, Larsson C, Gimm O, Söderkvist P.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1352-60. doi: 10.1210/jc.2013-4375.

PMID:
24694336
16.

Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.

Vicha A, Musil Z, Pacak K.

Curr Opin Endocrinol Diabetes Obes. 2013 Jun;20(3):186-91. doi: 10.1097/MED.0b013e32835fcc45. Review.

17.

Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in Western Sweden.

Muth A, Abel F, Jansson S, Nilsson O, Ahlman H, Wängberg B.

World J Surg. 2012 Jun;36(6):1389-94. doi: 10.1007/s00268-012-1430-6.

18.

Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.

Oishi Y, Nagai S, Yoshida M, Fujisawa S, Sazawa A, Shinohara N, Nonomura K, Matsuno K, Shimizu C.

Endocr J. 2010;57(8):745-50.

19.

Frequent genetic changes in childhood pheochromocytomas.

De Krijger RR, Petri BJ, Van Nederveen FH, Korpershoek E, De Herder WW, De Muinck Keizer-Schrama SM, Dinjens WN.

Ann N Y Acad Sci. 2006 Aug;1073:166-76. Erratum in: Ann N Y Acad Sci. 2006;1086:241. Petri, Bart-Jeroen [added].

PMID:
17102083
20.

Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.

Korpershoek E, Van Nederveen FH, Dannenberg H, Petri BJ, Komminoth P, Perren A, Lenders JW, Verhofstad AA, De Herder WW, De Krijger RR, Dinjens WN.

Ann N Y Acad Sci. 2006 Aug;1073:138-48.

PMID:
17102080

Supplemental Content

Support Center